Stocks股票 / Health Care / ISRG
ISRG US listed · USD美股 · 美元
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.直觉外科公司是一家美国生物技术公司,开发、制造和销售旨在通过微创手术改善患者临床结果的机器人产品,其中最著名的是达芬奇手术系统。
Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-07-21Earnings财务业绩
next report下次财报 2026-07-28Estimates being cut预期下调
Post-earnings drift: -11.6% (20d)财报后漂移:-11.6%(20日)
Valuation估值
Expensive vs sector相对行业偏贵| Multiple指标 | ISRG | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(历史) | 43.91x | 28.59 | |
| P/E (forward)市盈率(预测) | 29.4x | — | — |
| P/B市净率 | 7.04x | 3.44 | |
| P/S市销率 | 12.46x | 2.97 | |
| Earnings yield盈利收益率 | 2.28% | 2.72 | |
| FCF yield自由现金流收益率 | 1.99% | 4.00 | |
| Shareholder yield股东收益率 | 1.83% | 1.89 | |
| EV/EBITDA企业价值/EBITDA | 34.42x | 18.18 | |
| P/FCF市值/自由现金流 | 50.35x | 22.08 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Options positioning期权持仓
as of last close截至上一收盘Market makers are net short gamma — price moves may amplify做市商净持有负伽玛,价格波动可能被放大
Flow:资金流向: $64M premium traded; 33% 0DTE; 212 fresh positions; P/C 0.85; net new PUT positioning (defensive / hedging) (ΔOI +13,309); ~leans bullish (direction approx)成交权利金 $64M;0DTE占33%;212个新建仓;看跌看涨比 0.85;净新增看跌持仓(防御/对冲)(ΔOI +13,309);≈偏看涨(方向近似)
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: -$85.2M net (0 buyers, 9 sellers)-$85.2M 净值(0 买家,9 卖家)
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| RTW Investments | B | Adding加仓 | 1.0% | 2026-03-31 |
| Coatue Management | A | Holding持有 | 1.4% | 2026-03-31 |
| Perceptive Advisors | A | Holding持有 | 0.8% | 2026-03-31 |
| Polen Capital Management | B | trimtrim | 1.9% | 2026-03-31 |
| Giverny Capital | C | exitexit | 0.0% | 2026-03-31 |
Signal history信号历史
engine events引擎事件Company profile公司档案
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.直觉外科公司是一家美国生物技术公司,开发、制造和销售旨在通过微创手术改善患者临床结果的机器人产品,其中最著名的是达芬奇手术系统。
- Margin compression despite revenue growth
Recent news最新动态
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(静态) | 43.9× | 28.6× | 24% |
| P/E (forward)市盈率(预测) | 29.4× | — | — |
| Price / Book市净率 | 7.0× | 3.4× | 20% |
| Price / Sales市销率 | 12.5× | 3.0× | 7% |
| EV / EBITDAEV/EBITDA | 34.4× | 18.2× | 16% |
| Earnings yield盈利收益率 | 2.3% | 2.7% | 44% |
| Free-cash-flow yield自由现金流收益率 | 2.4% | 5.5% | 19% |
| Shareholder yield股东综合回报率 | 1.8% | 1.9% | 48% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -13.3% | -0.9% |
| 1 Month近1月 | -13.2% | -0.6% |
| 3 Months近3月 | -21.7% | +5.4% |
| 6 Months近6月 | -32.6% | +8.6% |
| Year to date年初至今 | -37.2% | +8.9% |
| 1 Year近1年 | -31.9% | +19.2% |
| 3 Years近3年 | +4.9% | +69.9% |
| 5 Years近5年 | +12.1% | +82.2% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $4.4B | $5.7B | $6.2B | $7.1B | $8.4B | $10.1B |
| EPS每股收益 | $8.82 | $4.66 | $3.65 | $5.03 | $6.42 | $7.87 |
| Free cash flow自由现金流 | $1.1B | $1.7B | $958M | $750M | $1.3B | $2.5B |
| Gross margin毛利率 | 65.6% | 69.3% | 67.4% | 66.4% | 67.5% | 66.0% |
| Net margin净利率 | 24.3% | 29.9% | 21.3% | 25.2% | 27.8% | 28.4% |
| FCF margin自由现金流利润率 | 26.2% | 30.4% | 15.4% | 10.5% | 15.6% | 24.7% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: accruals elevated vs peers (earnings lean on non-cash items)盈利质量:应计利润高于同业(盈利依赖非现金项目)
- Working capital: inventory +206% vs sales +131% — inventory building, demand risk营运资本:存货 +206% 对销售 +131%——存货积压,需求风险
- Pricing power: gross margin +0.4pts over 6 years定价能力:毛利率 6 年上升 0.4 个百分点
- Capital discipline: share count +201.7% over 6 years (dilution)资本纪律:股本 6 年增加 201.7%(稀释)
- Balance sheet: Altman Z 31.8 — safe zone资产负债表:Altman Z 31.8——安全区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Estimate revisions预期修正
Analyst view分析师观点
Dealer positioning map做市商持仓地图
Volatility pricing波动率定价
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| RTW Investments | B | Adding增持 | 1.0% | $101M |
| Coatue Management | A | Holding持有 | 1.4% | $394M |
| Perceptive Advisors | A | Holding持有 | 0.8% | $39M |
| Polen Capital Management | B | Trimming减持 | 1.9% | $280M |
| Giverny Capital | C | Exited清仓 | 0.0% | $229,376 |
Fund positioning基金持仓概览
Insiders & shorts内部人与空头
Recent fund flows近期基金流向
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 40% | -7.2% | 5 |
| Feb2月 | 80% | +0.4% | 5 |
| Mar3月 | 60% | +3.7% | 5 |
| Apr4月 | 40% | -0.2% | 5 |
| May5月 | 67% | +2.3% | 6 |
| Jun6月 | 50% | +8.9% | 6 |
| Jul7月 | 50% | +0.7% | 6 |
| Aug8月 | 40% | -1.5% | 5 |
| Sep9月 | 0% | -5.6% | 5 |
| Oct10月 | 80% | +8.8% | 5 |
| Nov11月 | 80% | +7.4% | 5 |
| Dec12月 | 40% | -1.1% | 5 |
- Jul: +8.6% avg, up 63% of years (n=27)7月:平均 +8.6%,63% 的年份上涨(n=27)